These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6339179)

  • 1. Failure of the commercial human IgG immunoglobulin preparation Polyglobin to enhance combined phagocytic and serum bactericidal activity of normal blood against Serratia marcescens.
    Traub WH
    Chemotherapy; 1983; 29(1):43-7. PubMed ID: 6339179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phagocytosis of Serratia marcescens by leukocytes of fresh defibrinated human blood: failure of "natural" human specific anti-O IgG antibodies to enhance phagocytosis.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):92-103. PubMed ID: 7032156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human serum bactericidal activity against Serratia marcescens: failure of human, "natural," specific anti-O IgG antibodies to enhance serum bactericidal activity.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):84-91. PubMed ID: 7032154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of a commercial, intravenously applicable IgG F (ab)2 preparation (Gamma-Venin) to enhance human serum bactericidal activity against Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 249(4):504-11. PubMed ID: 6171949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. III. beta-Lactam antibiotics and fosfomycin.
    Traub WH
    Chemotherapy; 1983; 29(1):48-57. PubMed ID: 6339180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Serratia marcescens to human serum: antagonism of serum bactericidal activity by IgG immunoglobulins of homologous rabbit anti-O sera.
    Traub WH
    Zentralbl Bakteriol A; 1980 Feb; 246(1):26-49. PubMed ID: 6158811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsonization requirements of Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Nov; 253(2):204-24. PubMed ID: 6187137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. I. Cotrimoxazole, nalidixic acid, nitrofurantoin, and trimethoprim.
    Traub WH
    Chemotherapy; 1982; 28(5):369-80. PubMed ID: 6754280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. II. Aminoglycosides: amikacin, gentamicin, and netilmicin.
    Traub WH
    Chemotherapy; 1982; 28(6):434-43. PubMed ID: 6761079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined serum bactericidal and phagocytic activities of defibrinated human blood against Serratia marcescens. Use of phenylbutazone to selectively block phagocytic killing activity and of Group A (phage tail) bacteriocins to kill extraphagocytic bacteria.
    Traub WH
    Chemotherapy; 1982; 28(5):355-62. PubMed ID: 6754279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. IV. N-formimidoyl thienamycin.
    Traub WH
    Chemotherapy; 1983; 29(2):121-7. PubMed ID: 6340990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further characterization of "promptly" and "delayed" human serum-sensitive strains of Serratia marcescens.
    Traub WH; Fukushima PI
    Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):495-511. PubMed ID: 44945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraphagocytic bactericidal activity of bacterial DNA gyrase inhibitors against Serratia marcescens.
    Traub WH
    Chemotherapy; 1984; 30(6):379-86. PubMed ID: 6097410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable neutralization of several nonspecific antibacterial systems in fresh, defibrinated human blood by sodium polyanetholsulfonate and sodium amylosulfate.
    Traub WH; Fukushima PI
    J Clin Microbiol; 1979 Jul; 10(1):27-31. PubMed ID: 227919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive protection of NMRI mice with commercial, intravenously applicable human immunoglobulin IgG preparations against Serratia marcescens.
    Traub WH
    Chemotherapy; 1986; 32(6):530-6. PubMed ID: 3542407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of human serum bactericidal activity by specific IgM antibodies of normal and anti-O immune rabbit sera against pseudo-serum-resistant strains of Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol A; 1980 Feb; 246(1):50-66. PubMed ID: 6999780
    [No Abstract]   [Full Text] [Related]  

  • 17. Inactivation of classical and alternative pathway-activated bactericidal activity of human serum by sodium polyanetholsulfonate.
    Traub WH; Kleber I
    J Clin Microbiol; 1977 Mar; 5(3):278-84. PubMed ID: 192756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host resistance to Serratia marcescens infection: serum bactericidal activity and phagocytosis by normal blood leukocytes.
    Simberkoff MS; Ricupero I; Rahal JJ
    J Lab Clin Med; 1976 Feb; 87(2):206-17. PubMed ID: 1107450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian serum susceptibility of Serratia marcescens: detection of three human serum susceptibility categories.
    Traub WH; Fukushima PI
    Zentralbl Bakteriol Orig A; 1979; 245(3):301-11. PubMed ID: 44784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of polymyxin B nonapeptide to augment bactericidal activities of novobiocin, rifampin, and of defibrinated human blood against Serratia marcescens.
    Traub WH; Kohl KH; Spohr M; Bauer D
    Chemotherapy; 1988; 34(3):195-201. PubMed ID: 2843325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.